Immunology of multisystem inflammatory syndrome after COVID-19 in children: a review of the current evidence

F Filippatos, EB Tatsi, A Michos - International Journal of Molecular …, 2023 - mdpi.com
Immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in children are still under investigation. Even though coronavirus disease 2019 (COVID …

[HTML][HTML] Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE …

F Sperotto, A Gutiérrez-Sacristán, S Makwana… - …, 2023 - thelancet.com
Background Multisystem inflammatory syndrome in children (MIS-C) is a severe
complication of SARS-CoV-2 infection. It remains unclear how MIS-C phenotypes vary …

Multisystem inflammatory syndrome in children (MIS-C): A nationwide collaborative study in the Greek population

S Lampidi, D Maritsi, M Charakida, I Eleftheriou… - European Journal of …, 2024 - Springer
Multisystem inflammatory syndrome in children (MIS-C) is a rare but severe
hyperinflammatory condition that may occur following SARS-CoV-2 infection. This …

[HTML][HTML] Complications of Multisystem Inflammatory Syndrome Associated with SARS-CoV-2 Infection—Many Facets of One Disease—A Literature Review Based on a …

A Stasiak, P Kędziora, E Smolewska - Journal of Clinical Medicine, 2024 - mdpi.com
Multisystem inflammatory syndrome in children (MIS-C) is a disease that made its mark in
the early days of the COVID-19 pandemic due to the diverse course and symptoms affecting …

The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis

MA Patel, DD Fraser, M Daley, G Cepinskas… - Molecular …, 2024 - Springer
Abstract Background The Multi-System Inflammatory Syndrome in Children (MIS-C) can
develop several weeks after SARS-CoV-2 infection and requires a distinct treatment …

MIS-C Treatment: Is glucocorticoid monotherapy enough for mild cases?

M Sütçü, EM Kara, F Yıldız, D Gül, R Yıldız… - The American Journal of …, 2024 - Elsevier
Background The effectiveness of using only glucocorticoids (GCs) in mild multisystem
inflammatory syndrome (MIS-C) cases was compared with combined treatment [GCs+ …

[HTML][HTML] Clinical and Laboratory Parameters Associated with PICU Admission in Children with Multisystem Inflammatory Syndrome Associated with COVID-19 (MIS-C)

MM Dourdouna, E Mpourazani, EB Tatsi… - Journal of Personalized …, 2024 - mdpi.com
Background/Objectives: Multisystem Inflammatory Syndrome in children (MIS-C) is a rare but
severe post-infectious complication of COVID-19 that often requires admission to the …

Epidemiological and clinical evolution of multisystem inflammatory syndrome in children throughout the SARS‐CoV‐2 pandemic in a tertiary Italian children's hospital

T Bellini, G Brisca, M Mariani, R Caorsi… - Acta …, 2024 - Wiley Online Library
Multisystem inflammatory syndrome in children (MIS‐C) is a potentially life‐threatening
disease temporally linked to SARS‐CoV‐2 whose incidence and clinical presentation may …

The complex landscape of immune dysregulation in multisystem inflammatory syndrome in children with COVID-19

J Guo, L Wang - Life Medicine, 2024 - academic.oup.com
The immune responses following SARS-CoV-2 infection in children are still under
investigation. While coronavirus disease 2019 (COVID-19) is usually mild in the paediatric …

Incidence and clinical phenotype of multisystem inflammatory syndrome in children after two SARS-CoV-2 pandemic waves: a Croatian prospective nationwide study

LS Marić, V Trkulja, D Petrović, KL Tomulić… - The Pediatric …, 2023 - journals.lww.com
This prospective nationwide study in Croatia (March 1, 2020–December 31, 2021)
embraced 121 children with multisystem inflammatory syndrome. Incidence rates, disease …